For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Gain Therapeutics Inc’s stock clocked out at $1.74, up 0.58% from its previous closing price of $1.73. In other words, the price has increased by $0.58 from its previous closing price. On the day, 0.26 million shares were traded. GANX stock price reached its highest trading level at $1.86 during the session, while it also had its lowest trading level at $1.71.
Ratios:
To gain a deeper understanding of GANX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 2.99. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.05.
On April 12, 2021, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $30.
On April 12, 2021, BTIG Research started tracking the stock assigning a Buy rating and target price of $30.BTIG Research initiated its Buy rating on April 12, 2021, with a $30 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 09 ’24 when Mack Gene bought 14,400 shares for $1.01 per share. The transaction valued at 14,544 led to the insider holds 14,400 shares of the business.
Islam Khalid bought 50,000 shares of GANX for $49,940 on Aug 09 ’24. The Executive Chairman now owns 50,000 shares after completing the transaction at $1.00 per share. On Jul 01 ’24, another insider, RICHMAN ERIC I, who serves as the Director of the company, bought 17,000 shares for $1.22 each. As a result, the insider paid 20,670 and bolstered with 289,629 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GANX now has a Market Capitalization of 46153676 and an Enterprise Value of 30984178.
Stock Price History:
Over the past 52 weeks, GANX has reached a high of $5.33, while it has fallen to a 52-week low of $0.89. The 50-Day Moving Average of the stock is -16.29%, while the 200-Day Moving Average is calculated to be -26.21%.
Shares Statistics:
It appears that GANX traded 385.19K shares on average per day over the past three months and 256850 shares per day over the past ten days. A total of 26.53M shares are outstanding, with a floating share count of 25.17M. Insiders hold about 5.09% of the company’s shares, while institutions hold 6.32% stake in the company. Shares short for GANX as of 1730332800 were 658341 with a Short Ratio of 1.87, compared to 1727654400 on 654274. Therefore, it implies a Short% of Shares Outstanding of 658341 and a Short% of Float of 2.71.
